CN1041495C

CN1041495C - External application medicine for curing hepatic disease

Info

Publication number: CN1041495C
Application number: CN 93110361
Authority: CN
Inventors: 李居富; 周京兰
Original assignee: Zibo City No1 Hospital
Current assignee: Zibo City No1 Hospital
Priority date: 1993-04-02
Filing date: 1993-04-02
Publication date: 1999-01-06
Anticipated expiration: 2013-04-02
Also published as: CN1078905A

Abstract

The present invention relates to a medicine for external application for treating liver diseases, which is prepared from traditional Chinese medicines for heat-clearing and detoxifying, traditional Chinese medicines for promoting blood circulation and removing blood stasis, traditional Chinese medicines for soothing the liver and regulating the circulation of qi, traditional Chinese medicines for warming yang and traditional Chinese medicines for inducing resuscitation. The Chinese medicines are pulverized and made into a medicinal mat. The medicinal mat can be directly applied to the body surface region of the liver, and has the advantages of good osmosis, concentrated medicinal potency and better curative effects on treating hepatitis and liver diseases of the depression of liver-qi, the stagnation of the liver-qi, etc. mentioned in the traditional Chinese medical theory.

Description

A kind of medicine for external use for the treatment of hepatopathy

The invention belongs to the Chinese medicine class, be a kind of medicine for external use for the treatment of hepatopathy.

At present, Western medicine does not still have the specific treatment method to viral hepatitis.Chinese medicine has significantly curative effect to hepatopathys such as the depression of liver-QI of hepatitis and traditional Chinese medical science indication, liver whats, yet traditional oral medication method is a systemic administration, and systemic administration target organ drug level is low, affects the treatment; Oral medication also has zest to gastrointestinal tract, and patient is difficult to tolerate the normal phase and takes medicine; The decocting dosage form, the process of boiling medicine complexity is taken inconvenience, because these deficiencies have influenced the use and the curative effect of medicine.

The objective of the invention is to inner disease outer treat, a kind of medicine for external use is provided, directly act on the body surface position of liver, hepatoprotective is treated liver diseases such as hepatitis effectively.

The objective of the invention is to realize in the following manner:

The medicine for external use of treatment hepatopathy is made up of antipyretic and antidotal type Chinese medicine, invigorating blood circulation what class Chinese medicine, liver-smoothing, qi-regulating class Chinese medicine, warming YANG class Chinese medicine, the class of having one's ideas straightened out Chinese medicine, wherein:

Antipyretic and antidotal type Chinese medicine is made up of Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae, and each Chinese medicine accounts for the 1-11% of described medicine for external use gross weight;

Invigorating blood circulation what class Chinese medicine is made up of Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae, and each Chinese medicine accounts for the 1-5% of described medicine for external use gross weight;

Liver-smoothing, qi-regulating class Chinese medicine is made up of Herba Artemisiae Anomalae, the Radix Aucklandiae, Fructus Amomi, Pericarpium Citri Reticulatae Viride, roud cardamon seed, Pericarpium Citri Reticulatae, and each Chinese medicine accounts for the 2-5% of described medicine for external use gross weight;

Warming YANG class Chinese medicine is made up of Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi, and each Chinese medicine accounts for the 2-12% of described medicine for external use gross weight;

The class of having one's ideas straightened out Chinese medicine is made up of Rhizoma Acori Graminei and Borneolum Syntheticum, and each Chinese medicine accounts for the 1-2% of described medicine for external use gross weight

To account for the preferred value of described medicine for external use gross weight be 3～7% to each Chinese medicine in the above-mentioned antipyretic and antidotal type Chinese medicine, and to account for the preferred value of described medicine for external use gross weight be 3～7% to each Chinese medicine in the warming YANG class Chinese medicine.

Herba Taraxaci can replace with Herba Houttuyniae in the antipyretic and antidotal type Chinese medicine preparation, also can have simultaneously by two kinds of Chinese medicines.

Radix Salviae Miltiorrhizae can replace with the Herba Lycopi in the invigorating blood circulation what class Chinese medicine, also can two kinds all adds in the prescription.

The class of having one's ideas straightened out Chinese medicine can be selected Rhizoma Acori Graminei, Borneolum Syntheticum for use, preferably is made up of Rhizoma Acori Graminei, Borneolum Syntheticum.

Chinese crude drug processing powder of the present invention is broken into smalls, evenly is sprinkling upon on the multilamellar gauze, and sewing it up is medicated cushion, and medicated cushion acts on liver body surface position, as makes vest, makes interlayer and stays mouth at the position, hepatic region, is the vest that can treat hepatopathy behind the placement medicated cushion.General drug effect continues about one month.

Advantage of the present invention: medicine directly acts on the body surface position good penetrability of liver, the efficacy of a drug is concentrated, improve than the systemic administration curative effect, removed the complex process of water decoction type, avoided oral drugs that gastrointestinal is stimulated, for the symptom of improving hepatitis patient and sign, recovering liver function is significantly improved than simple liver protecting therapy, has the adjusting vegetative nerve function, strengthened body immunity, enliven liver microcirculation, promote the reparation and the regeneration of liver, hepatopathys such as the depression of liver-QI of treatment hepatitis and traditional Chinese medical science indication, liver what are had curative effect preferably.

Clinical case:

With * *, woman, 35 years old, the workman of Boshan rubber plant, trouble hepatitis year is surplus, and the patient is surplus February through hospitalization, after leaving hospital, improvement still feels weak, liver pain discomfort, poor appetite, though it is still not obvious that routine is taken the hepatic effect, after wear the medicinal vest that the present invention makes, liver pain alleviates after 5 months, fade away, food is received increases thereupon, weak alleviating, state of an illness consolidation.

Embodiment one:

The present invention is made up of following medicine:

Herba Pogostemonis 1%, Herba Eupatorii 3%, Herba Taraxaci 7%, Herba Artemisiae Scopariae 11%, Rhizoma Atractylodis 5%, the Radix Stemonae 2%, Rhizoma Chuanxiong 1%, Rhizoma Curcumae 3%, Flos Carthami 5%, Radix Salviae Miltiorrhizae 4%, Radix Angelicae Sinensis 1%, Radix Curcumae 2%, Rhizoma Corydalis 3%, Rhizoma Curcumae Longae 5%, Herba Artemisiae Anomalae 2%, the Radix Aucklandiae 5%, Fructus Amomi 4%, Pericarpium Citri Reticulatae Viride 3%, roud cardamon seed 2%, Pericarpium Citri Reticulatae 5%, Rhizoma Alpiniae Officinarum 3%, Fructus Evodiae 11%, Flos Caryophylli 2%, Cortex Cinnamomi 7%, Rhizoma Acori Graminei 2%, Borneolum Syntheticum 1%.

The said medicine processing powder is broken into smalls, evenly is sprinkling upon on the multilamellar gauze, around fixedly being medicated cushion, makes vest with sewing machine, puts into medicated cushion at the position, hepatic region.

Embodiment two:

Herba Pogostemonis 11%, Herba Eupatorii 5%, Herba Taraxaci 1%, Herba Artemisiae Scopariae 1%, Rhizoma Atractylodis 7%, the Radix Stemonae 11%, Rhizoma Chuanxiong 5%, Rhizoma Curcumae 1%, Flos Carthami 1%, Radix Salviae Miltiorrhizae 2%, Radix Angelicae Sinensis 3%, Radix Curcumae 5%, Rhizoma Corydalis 1%, Rhizoma Curcumae Longae 3%, Herba Artemisiae Anomalae 5%, the Radix Aucklandiae 2%, Fructus Amomi 2%, Pericarpium Citri Reticulatae Viride 5%, roud cardamon seed 5%, Pericarpium Citri Reticulatae 2%, Rhizoma Alpiniae Officinarum 12%, Fructus Evodiae 2%, Flos Caryophylli 4%, Cortex Cinnamomi 2%, Rhizoma Acori Graminei 1%, Borneolum Syntheticum 1%.

Embodiment three:

Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae each 1%, Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae each 2%, Radix Angelicae Sinensis 3%, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae each 1%, Herba Artemisiae Anomalae, the Radix Aucklandiae, Fructus Amomi, Pericarpium Citri Reticulatae Viride, roud cardamon seed, Pericarpium Citri Reticulatae each 5%, Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi each 12%, Rhizoma Acori Graminei, Borneolum Syntheticum 1%.

Embodiment four:

Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci, Artemisia anethoicles Mattf, Rhizoma Atractylodis, the Radix Stemonae, Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi each 5%, Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae, roud cardamon seed, Pericarpium Citri Reticulatae Viride, Fructus Amomi, the Radix Aucklandiae, Herba Artemisiae Anomalae each 3.33%, Rhizoma Acori Graminei, Borneolum Syntheticum each 1.69%.

Claims

1, a kind of medicine for external use for the treatment of hepatopathy, it is characterized in that by weight percentage, by Herba Pogostemonis 1-11%, Herba Eupatorii 1-11%, Herba Taraxaci 1-11%, Herba Artemisiae Scopariae 1-11%, Rhizoma Atractylodis 1-11%, Radix Stemonae 1-11%, Rhizoma Chuanxiong 1-5%, Rhizoma Curcumae 1-5%, Flos Carthami 1-5%, Radix Salviae Miltiorrhizae 1-5%, Radix Angelicae Sinensis 1-5%, Radix Curcumae 1-5%, Rhizoma Corydalis 1-5%, Rhizoma Curcumae Longae 1-5%, Herba Artemisiae Anomalae 2-5%, Radix Aucklandiae 2-5%, Fructus Amomi 2-5%, Pericarpium Citri Reticulatae Viride 2-5%, roud cardamon seed 2-5%, Pericarpium Citri Reticulatae 2-5%, Rhizoma Alpiniae Officinarum 2-12%, Fructus Evodiae 2-12%, Flos Caryophylli 2-12%, Cortex Cinnamomi 2-12%, Rhizoma Acori Graminei 1-2%, Borneolum Syntheticum 1-2% forms.

2, medicine for external use according to claim 1 is characterised in that wherein said Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae respectively are 3～7%, and Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi respectively are 3～7%.